Professor PaoloVineis is a leading researcher in the fields of molecular epidemiology and exposomics. His latest research activities mainly focus on examining biomarkers of disease risk, complex exposures and intermediate biomarkers from omic platforms (including metabolomics and epigenetics) in large epidemiological studies as well as studying the effects of climate change on non-communicable diseases. He has more than 800 publications (many as leading author) in journals such as Nature, Nature Genetics, Lancet, Lancet Oncology. He is a member of various international scientific and ethics committees (including the Committee of the US National Academy of Sciences on 21st Century Risk Assessment) and vice-chair of the Ethics Committee at the International Agency for Research on Cancer (IARC,WHO). He has been a member of the Scientific Council of IARC. Professor Vineis has extensive experience in leading International projects. He is currently coordinating the European Commission funded Exposomics project (valued at €8.7m, started in 2012) and the Horizon 2020-funded project Lifepath (valued at €6 million, started in 2015). He is a Principal Investigator/Co-investigator of numerous international research projects, such as the European Commission funded GENAIR, ECNIS2, Envirogenomarkers, Hypergenes, ESCAPE and Transphorm networks, in which he has led WorkPackages. In addition he has attracted grants from the Leverhulme Trust, MRC, Cancer Research UK, and the US National Cancer Institute. He is the director of the Unit of Molecular and Genetic Epidemiology, HuGeF Foundation, Torino, Italy and leads the Exposome and Health theme of the MRC-PHE Centre for Environmentand Health at Imperial College.